Interleukin 16 expression changes in association with ovarian malignant transformation

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 3, 2014, Pages 272.e1-272.e10

  Yellapa, Aparna ^a   Bitterman, Pincas ^a   Sharma, Sameer ^a   Guirguis, Alfred S ^a   Bahr, Janice M ^b   Basu, Sanjib ^a   Abramowicz, Jacques S ^c   Barua, Animesh ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

interleukin 16; laying hen model; malignant transformation; ovarian cancer

Indexed keywords

INTERLEUKIN 16;

ADULT; AGED; ANIMAL TISSUE; BENIGN TUMOR; CANCER GROWTH; CANCER STAGING; CHICKEN; CONFERENCE PAPER; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MICROVASCULATURE; MIDDLE AGED; NONHUMAN; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; VERY ELDERLY;

INTERLEUKIN 16; LAYING HEN MODEL; MALIGNANT TRANSFORMATION; OVARIAN CANCER;

ADULT; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-16; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY;

EID: 84894596419     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.12.041     Document Type: Conference Paper

References (52)

1. R.D. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. L.A. Ries Ovarian cancer: survival and treatment differences by age Cancer 71 Suppl 1993 524 529
3. M.T. Goodman, C.N. Correa, and K.H. Tung et al. Stage at diagnosis of ovarian cancer in the United States, 1992-1997 Cancer 97 Suppl 2003 2648 2659
4. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 2000 3 10
5. R.G. Moore, and R.C. Bast Jr. How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above J Clin Oncol 25 2007 4159 4161
6. K. Bosse, K. Rhiem, and B. Wappenschmidt et al. Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study Gynecol Oncol 103 2006 1077 1082
7. U. Menon, A. Gentry-Maharaj, and I. Jacobs Ovarian cancer screening and mortality JAMA 306 2011 1544 1545
8. R. Yigit, L.F. Massuger, C.G. Figdor, and R. Torensma Ovarian cancer creates a suppressive microenvironment to escape immune elimination Gynecol Oncol 117 2010 366 372
9. R. Vang, I.M. Shih, and R.J. Kurman Fallopian tube precursors of ovarian low- and high-grade serous neoplasms Histopathology 62 2013 44 58
10. E. Kuhn, R.J. Kurman, and I.M. Shih Ovarian cancer is an imported disease: fact or fiction? Curr Obstet Gynecol Rep 1 2012 1 9
11. L.N. Heidemann, D. Hartwell, C.H. Heidemann, and K.M. Jochumsen The relation between endometriosis and ovarian cancer-a review Acta Obstet Gynecol Scand 93 2014 20 31
12. C.C. Buis, F.E. van Leeuwen, T.M. Mooij, and C.W. Burger Increased risk for ovarian cancer and borderline ovarian tumors in subfertile women with endometriosis Hum Reprod 28 2013 3358 3369
13. D. Zink, A.H. Fischer, and J.A. Nickerson Nuclear structure in cancer cells Nat Rev Cancer 4 2004 677 687
14. A. Maccio, and C. Madeddu Inflammation and ovarian cancer Cytokine 58 2012 133 147
15. W.W. Cruikshank, H. Kornfeld, and D.M. Center Interleukin-16 J Leukoc Biol 67 2000 757 766
16. G.L. Chupp, E.A. Wright, and D. Wu et al. Tissue and T-cell distribution of precursor and mature IL-16 J Immunol 161 1998 3114 3119
17. + T cells is activation dependent J Immunol 162 1999 1287 1293
18. A. Elssner, A.I. Doseff, M. Duncan, M. Kotur, and M.D. Wewers IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis J Immunol 172 2004 7721 7725
19. K.G. Lim, H.C. Wan, and P.T. Bozza et al. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES J Immunol 156 1996 2566 2570
20. D.M. Center, H. Kornfeld, and W.W. Cruikshank Interleukin-16 Int J Biochem Cell Biol 29 1997 1231 1234
21. E. Kovacs The serum levels of IL-12 and IL-16 in cancer patients: relation to the tumor stage and previous therapy Biomed Pharmacother 55 2001 111 116
22. G. Bellomo, A. Allegra, and A. Alonci et al. Serum levels of interleukin-16 in lymphoid malignancies Leuk Lymphoma 48 2007 1225 1227
23. A.A. Tone, C. Virtanen, P. Shaw, and T.J. Brown Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis Clin Cancer Res 18 2012 4334 4344
24. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1990 4 6
25. S. Ramakrishnan, I.V. Subramanian, Y. Yokoyama, and M. Geller Angiogenesis in normal and neoplastic ovaries Angiogenesis 8 2005 169 182
26. N.L. Mathy, W. Scheuer, and M. Lanzendorfer et al. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes Immunology 100 2000 63 69
27. A.L. Angiolillo, H. Kanegane, C. Sgadari, G.H. Reaman, and G. Tosato Interleukin-15 promotes angiogenesis in vivo Biochem Biophys Res Commun 233 1997 231 237
28. A. Simonini, M. Moscucci, and D.W. Muller et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue Circulation 101 2000 1519 1526
29. F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217
30. A. Barua, P. Bitterman, and J.S. Abramowicz et al. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer Int J Gynecol Cancer 19 2009 531 539
31. A. Barua, A. Yellapa, and J.M. Bahr et al. Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer Transl Oncol 5 2012 260 268
32. M.F. Khan, J.M. Bahr, and A. Yellapa et al. Expression of leukocyte inhibitory immunoglobulin-like transcript 3 receptors by ovarian tumors in laying hen model of spontaneous ovarian cancer Transl Oncol 5 2012 85 91
33. D.B. Hales, Y. Zhuge, and J.A. Lagman et al. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus) Endocrine 33 2008 235 244
34. K. Ansenberger, Y. Zhuge, and J.A. Lagman et al. E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer Gynecol Oncol 113 2009 362 369
35. A. Yellapa, J.M. Bahr, and P. Bitterman et al. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer Int J Gynecol Cancer 22 2012 199 207
36. A. Barua, P. Bitterman, and J.M. Bahr et al. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer J Ultrasound Med 29 2010 173 182
37. A. Barua, M.J. Bradaric, and T. Kebede et al. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer Am J Reprod Immunol 57 2007 243 249
38. A. Barua, T. Qureshi, and P. Bitterman et al. Molecular targeted imaging of vascular endothelial growth factor receptor (VEGFR)-2 and anti-NMP autoantibodies detect ovarian tumor at early stage Cancer Res 72 Suppl 2012 Abstract nr 2455. doi: 1538-7445.AM2012-2455.
39. E. Yu, H. Lee, W. Oh, B. Yu, H. Moon, and I. Lee Morphological and biochemical analysis of anti-nuclear matrix protein antibodies in human sera J Korean Med Sci 14 1999 27 33
40. K. Penumatsa, S.L. Edassery, A. Barua, M.J. Bradaric, and J.L. Luborsky Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors J Ovarian Res 3 2010 28
41. M.A. Nash, G. Ferrandina, M. Gordinier, A. Loercher, and R.S. Freedman The role of cytokines in both the normal and malignant ovary Endocr Relat Cancer 6 1999 93 107
42. S. Laberge, P. Ernst, and O. Ghaffar et al. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma Am J Respir Cell Mol Biol 17 1997 193 202
43. M. Arima, J.R. Plitt, C. Stellano, L.M. Schwiebert, and R.P. Schleimer The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells J Allergy Clin Immunol 97 1996 443
44. M.L. Cho, Y.O. Jung, and K.W. Kim et al. IL-17 induces the production of IL-16 in rheumatoid arthritis Exp Mol Med 40 2008 237 245
45. D. Seegert, P. Rosenstiel, H. Pfahler, P. Pfefferkorn, S. Nikolaus, and S. Schreiber Increased expression of IL-16 in inflammatory bowel disease Gut 48 2001 326 332
46. K. Koga, Y. Osuga, and O. Yoshino et al. Elevated interleukin-16 levels in the peritoneal fluid of women with endometriosis may be a mechanism for inflammatory reactions associated with endometriosis Fertil Steril 83 2005 878 882
47. D. Atanackovic, Y. Hildebrandt, and J. Templin et al. Role of interleukin 16 in multiple myeloma J Natl Cancer Inst 104 2012 1005 1020
48. Y. Zhang, H. Kornfeld, W.W. Cruikshank, S. Kim, C.C. Reardon, and D.M. Center Nuclear translocation of the N-terminal prodomain of interleukin-16 J Biol Chem 276 2001 1299 1303
49. F.T. Stevenson, J. Turck, R.M. Locksley, and D.H. Lovett The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein Proc Natl Acad Sci U S A 94 1997 508 513
50. E.J. Nam, H. Yoon, and S.W. Kim et al. MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2008 2690 2695
51. N. Nishida, K. Mimori, and M. Fabbri et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab Clin Cancer Res 17 2011 2725 2733
52. L. Zhang, S.K. Sun, L.X. Shi, and X. Zhang Serum cytokine profiling of prostate cancer and benign prostatic hyperplasia using recombinant antibody microarray [in Chinese] Zhonghua Nan Ke Xue 16 2010 584 588